Magnetic Resonance Angiography Market - Global Forecast 2025-2032

The magnetic resonance angiography market is in a period of significant evolution as healthcare leaders respond to emerging technology, shifting regulations, and rising clinical expectations. This dynamic environment presents opportunities and challenges for industry executives seeking operational efficiency and competitive differentiation in diagnostic imaging.

Market Snapshot: Magnetic Resonance Angiography Market Overview

The global magnetic resonance angiography market demonstrates steady expansion, with global revenues expected to increase from USD 3.23 billion in 2024 to USD 3.60 billion in 2025. Analysts project this upward trend to continue, supported by a CAGR of 11.38% and a projected value of USD 7.67 billion by 2032. Central to this growth are rapid advancements in imaging technology and digital workflow integration, which are enabling wider adoption across both established and developing healthcare infrastructures. These advances affirm the market's critical role in supporting precision diagnostics, enhanced patient outcomes, and streamlined care management.

Scope & Segmentation

This report offers comprehensive analysis of the magnetic resonance angiography market, detailing critical product and technology categories, applications, end-user groups, and major geographic regions. Stakeholders can leverage this segmentation to navigate complex procurement, adoption, and investment decisions.

• Product Types: Accessories and consumables, service packages, and imaging systems are included, spanning both high field and low field strength platform options for diverse clinical demands.
• Field Strength Options: Both high field and low field models are examined, catering to requirements across a wide range of healthcare facility profiles and patient populations.
• Technology Approaches: The analysis covers contrast enhanced, phase contrast, quiescent interval single shot, and time-of-flight imaging techniques, each with unique diagnostic and workflow benefits.
• Applications: Procedures under cardiovascular, neurovascular, and peripheral vascular domains—including both lower and upper limb imaging—are assessed for their impact on patient care and diagnostic accuracy.
• End User Environments: Academic research institutes, ambulatory surgical centers, diagnostic imaging centers, and hospitals are all profiled for their usage patterns and technology requirements.
• Regional Coverage: The analysis spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, with detailed insights on the United States, Canada, Brazil, the United Kingdom, Germany, France, China, India, Japan, and Australia, among others.
• Company Coverage: Leading firms such as Siemens Healthineers AG, GE Healthcare, Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, and other significant market players are profiled for competitive intelligence.

Magnetic Resonance Angiography: Key Takeaways

• Magnetic resonance angiography is recognized as a noninvasive solution, reducing reliance on radiation and invasive catheter-based diagnostics, while supporting both early detection and continuous disease surveillance.
• Ongoing advancements in magnet design, gradient coil engineering, and AI-driven optimization contribute to improved image clarity, enhanced workflow, and measurable operational efficiency for healthcare teams.
• Innovations such as silent scanning protocols and adaptable scanner configurations are making the technology more accessible, extending its reach to previously underserved clinical environments.
• Both service models and complete system offerings meet varied needs—from advanced protocol development in research institutions to efficient, user-friendly solutions in outpatient and ambulatory care settings.
• Collaborations among equipment manufacturers, software innovators, and healthcare providers are driving the development of modular upgrades and integrated diagnostic solutions, promoting scalability and adaptability.

Tariff Impact on the Magnetic Resonance Angiography Sector

Recent tariff adjustments in the United States have altered supplier strategies and increased input costs across the angiography supply chain. Key components, including gradient coils, superconducting wires, and radiofrequency antennas, now face elevated tariffs, prompting re-evaluation of supplier relationships and vendor contracts. In response, industry participants are emphasizing local partnerships and modular product enhancements, with an emphasis on mitigating procurement delays and managing cost pressures.

Methodology & Data Sources

Our research synthesizes qualitative interviews with industry executives and key clinical stakeholders, supported by in-depth review of regulatory submissions, scientific literature, and reports from leading trade associations. Findings are validated using robust segmentation-driven analysis, ensuring actionable guidance for senior decision-makers.

Why This Report Matters

• Enables executives to pinpoint strategic opportunities, anticipate emerging trends, and address unique challenges specific to both regions and market segments.
• Presents a clear view of competitive positioning, emerging organizations, and partnership structures driving technological advancement and sustained differentiation.
• Supports data-driven investment and operational planning, providing evidence-based insights on regulatory dynamics, supply chain resilience, and digital transformation strategies.

Conclusion

The magnetic resonance angiography market is transforming as stakeholders align with innovation and regulatory nuances. Proactive strategy and collaboration remain central for those aiming to achieve long-term growth and strengthen their leadership positions.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.